{"id":44775,"title":"Trajectories of Glucocorticoid-Therapy  After Initiation in Early (or Methotrexate-Naive) Rheumatoid Arthritis:  Protocol for a Systematic Review, Meta-Analysis and Meta-Regression of  Observational Cohort Studies","title_html":"<p>Trajectories of Glucocorticoid-Therapy  After Initiation in Early (or Methotrexate-Naive) Rheumatoid Arthritis:  Protocol for a Systematic Review, Meta-Analysis and Meta-Regression of  Observational Cohort Studies<\/p>","image":{"source":"https:\/\/www.protocols.io\/img\/default_protocol.png","placeholder":"https:\/\/www.protocols.io\/img\/default_protocol.png"},"doi":null,"doi_status":0,"uri":"trajectories-of-glucocorticoid-therapy-after-initi-bpyfmptn","type_id":1,"template_id":1,"published_on":1606063046,"parent_protocols":[],"parent_collections":[],"cited_protocols":[],"version_id":0,"version_data":{"id":"0","code":"bpyfmptn","parent_id":0,"parent_uri":null,"is_same_owner":false,"has_pending_merge_request":false,"has_approved_merge_request":false},"created_on":1606051110,"modified_on":null,"categories":null,"public":1,"is_unlisted":0,"creator":{"name":"Andriko Palmowski","affiliation":"Department of Rheumatology and Clinical Immunology, Charit\u00e9 - University Medicine Berlin, Germany","affiliations":[{"affiliation":"Department of Rheumatology and Clinical Immunology, Charit\u00e9 - University Medicine Berlin, Germany","url":"http:\/\/www.charite.de\/","is_default":1}],"username":"andriko-palmowski","note":null,"link":null,"image":{"source":"\/img\/avatars\/009.png","placeholder":"\/img\/avatars\/009.png"},"badges":[{"id":2,"image":{"source":"\/img\/badges\/bronze.svg","placeholder":"\/img\/badges\/bronze.svg"},"name":"Author"}],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},"journal":null,"journal_name":null,"journal_link":null,"article_citation":null,"has_versions":0,"link":null,"total_collections":0,"number_of_steps":6,"authors":[{"name":"Andriko Palmowski","affiliation":"Department of Rheumatology and Clinical Immunology, Charit\u00e9 - University Medicine Berlin, Germany","affiliations":[],"username":"andriko-palmowski","note":null,"link":null,"image":{"source":"\/img\/avatars\/009.png","placeholder":"\/img\/avatars\/009.png"},"badges":[],"verified":1,"is_verified_user":true,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false},{"name":"Frank Buttgereit","affiliation":"Department of Rheumatology and Clinical Immunology, Charit\u00e9 - University Medicine Berlin, Germany","affiliations":[],"username":null,"note":null,"link":null,"image":{"source":null,"placeholder":null},"badges":[],"verified":0,"is_verified_user":false,"research_interests":null,"blocked_by_you":false,"blocked_you":false,"hide_following":false}],"versions":[],"groups":[],"is_owner":1,"has_subprotocols":0,"is_subprotocol":0,"is_bookmarked":0,"can_claim_authorship":0,"can_accept_authorship":0,"can_be_copied":1,"can_remove_fork":1,"fork_id":null,"url":"https:\/\/www.protocols.io\/view\/trajectories-of-glucocorticoid-therapy-after-initi-bpyfmptn","forks_count":{"private":0,"public":0},"access":{"can_view":1,"can_remove":1,"can_add":0,"can_edit":0,"can_publish":0,"can_get_doi":1,"can_share":1,"can_move":1,"can_move_outside":1,"can_transfer":1,"can_download":1,"is_locked":0},"guid":"35932FB02CC511EB88764D9CA6BE3E7C","state_version_id":131,"steps":[{"id":1079726,"guid":"36D0B8C02CC511EB88764D9CA6BE3E7C","previous_id":null,"previous_guid":null,"modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"22BF1C4438724DE7A7DECB82A1B978F3","order_id":1,"type_id":6,"title":"Section","source":{"title":"Objective"}},{"id":1054724,"guid":"5C5BF60BAA6046B6A5B9591C31F9E997","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">To assess real-world trajectories of glucocorticoid-therapy initiated as part of early rheumatoid arthritis (RA) treatment.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#A492FF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1079728,"guid":"C9F30AE02CC511EB88764D9CA6BE3E7C","previous_id":1079726,"previous_guid":"36D0B8C02CC511EB88764D9CA6BE3E7C","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"78AB4481642B44E8985947C6A99352A3","order_id":1,"type_id":6,"title":"Section","source":{"title":"Eligibility"}},{"id":1054724,"guid":"C36B2655096645DA851DD4A2A6256515","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Observational cohort studies (CS) published between Jan 01, 2005 and now. Studies must enroll early (or methotrexate-naive) RA patients and report on those starting\/taking systemic glucocorticoids (GCs) at baseline and describe at least one of our outcomes at two time points minimum.<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#94EBFF","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1079729,"guid":"D7569FD02CC511EB88764D9CA6BE3E7C","previous_id":1079728,"previous_guid":"C9F30AE02CC511EB88764D9CA6BE3E7C","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"A0E3395A57F94F568C9ECD72CB18ADA3","order_id":1,"type_id":6,"title":"Section","source":{"title":"Data Source"}},{"id":1054724,"guid":"AD5809582ADA45E8A757C09785D2BE2B","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">MEDLINE (via PubMed). <\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#84CE84","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1079730,"guid":"27738F002CCB11EB88764D9CA6BE3E7C","previous_id":1079729,"previous_guid":"D7569FD02CC511EB88764D9CA6BE3E7C","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"06890D6F402A49BBA2B3A9656439E9A9","order_id":1,"type_id":6,"title":"Section","source":{"title":"Search Strings"}},{"id":1054724,"guid":"58F63AD03B99475F9C133C24CE27043B","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Search strings were developed utilizing the PICOS mnemonic:<\/div><div class = \"text-block\"><div class = \"justify\" style = \"text-align:justify\"><span style = \"font-weight:bold;\">P<\/span><span>opulation: early (or methotrexate-na\u00efve) RA - <\/span><span style = \"font-weight:bold;\">I<\/span><span>ntervention: systemic GCs - <\/span><span style = \"font-weight:bold;\">C<\/span><span>omparator: any - <\/span><span style = \"font-weight:bold;\">O<\/span><span>utcome: any - <\/span><span style = \"font-weight:bold;\">S<\/span><span>tudy design: observational cohort study<\/span><\/div><style>\n\t\t\t\t\t\t\t  .justify:after {\n\t\t\t\t\t\t\t    content: \"\";\n\t\t\t\t\t\t\t    display:inline-block;\n\t\t\t\t\t\t\t    width: 100%;\n\t\t\t\t\t\t\t  }\n\t\t\t\t\t\t\t<\/style><\/div><div class = \"text-block\">(Rheumatoid[Title] OR Arthritis, Rheumatoid[MeSh:NoExp]) <\/div><div class = \"text-block\"><span style = \":UNDERLINE;\">AND<\/span><span> (early[title\/abstract] OR na\u00efve[title\/abstract]) <\/span><\/div><div class = \"text-block\"><span style = \":UNDERLINE;\">AND<\/span><span> (Cortison*[title\/abstract] OR Predniso*[title\/abstract] OR Cortico*[title\/abstract] OR Glucocort*[title\/abstract] OR Steroid*[title\/abstract] OR Glucocorticoids[MeSh:NoExp]) <\/span><\/div><div class = \"text-block\"><span style = \":UNDERLINE;\">AND<\/span><span> (Cohort[Title\/Abstract] OR Longitudinal[Title\/Abstract] OR Prospective[Title\/Abstract] OR Registry[Title\/Abstract] OR Longitudinal Studies[Mesh:NoExp] OR Cohort Studies[Mesh:NoExp] OR Registries[Mesh:NoExp]) <\/span><\/div><div class = \"text-block\"><span style = \":UNDERLINE;\">AND<\/span><span> 2005\/01\/01:2021\/01\/01[dp] <\/span><\/div><div class = \"text-block\"><span style = \":UNDERLINE;\">NOT<\/span><span> (random*[Title] OR randomized controlled trial[pt])<\/span><\/div><div class = \"text-block\"><span style = \":UNDERLINE;\">NOT<\/span><span> (review[Title] or review[pt])<\/span><\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#FFED92","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1079731,"guid":"5E5230802CCB11EB88764D9CA6BE3E7C","previous_id":1079730,"previous_guid":"27738F002CCB11EB88764D9CA6BE3E7C","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"5A8C94F6A63F4825B93A789E61919CC7","order_id":1,"type_id":6,"title":"Section","source":{"title":"Outcomes"}},{"id":1054724,"guid":"F27E56977FD049E6A5E5C0F598054F69","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Mean\/median dose of prednisone equivalent, proportion of patients who could discontinue GCs, proportion of patients who could reduce GCs (all: at baseline, 3, 6, 9, 12, and 24 months).<\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#EA9F6C","section_duration":0,"critical":null,"critical_id":null,"duration":0},{"id":1079732,"guid":"677499502CCB11EB88764D9CA6BE3E7C","previous_id":1079731,"previous_guid":"5E5230802CCB11EB88764D9CA6BE3E7C","modified_on":0,"protocol_id":0,"components":[{"id":1054723,"guid":"111D2693197B42998EEA08E59A220DD8","order_id":1,"type_id":6,"title":"Section","source":{"title":"Data Synthesis"}},{"id":1054724,"guid":"5879319CEDA94635B1A24DFF784B6E36","order_id":1,"type_id":1,"title":"description","source":{"description":"<div class = \"text-blocks\"><div class = \"text-block\">Meta-analysis will be conducted to pool results, including meta-regression (mixed effects) to assess change over time for each outcome. <\/div><\/div>"}}],"cases":[],"data":null,"html":null,"section":null,"section_color":"#E57785","section_duration":0,"critical":null,"critical_id":null,"duration":0}],"document":null,"materials":[],"description":null,"changed_on":1606063046}